Dopamine and the parkinsonism-chorea antagonism
Bulandra, R.; Serbanesco, A.
Revue Neurologique (Paris) 127(2): 315
1972
ISSN/ISBN: 0035-3787 PMID: 4147105 Document Number: 51485
Document emailed within 1 workday
Related Documents
Tanji, H.; Nagasawa, H.; Itoh, M.; Itoyama, Y. 1997: PET study of dopamine metabolism and dopamine D2 receptor in juvenile parkinsonism Nihon Rinsho. Japanese Journal of Clinical Medicine 55(1): 89-94Kryzhanovskiĭ, G.N.; Atadzhanov, M.A.; Magaeva, S.V.; Basharova, L.A.; Vetrilé, L.A. 1989: EEG changes and symptomatic parkinsonism after intracaudate administration of dopamine antibodies Biulleten' Eksperimental'noi Biologii i Meditsiny 107(1): 13-16
Berga, P.; Beckett, P.R.; Roberts, D.J. 1979: Antagonism of pre- and postsynaptic dopamine receptors by clebopride and related orthopramides Archivos de Farmacologia y Toxicologia 5(3): 144-146
Khare, P.; Jain, A.; Jain, N.K.; Soni, V.; Jain, S.K. 2009: Glutamate-conjugated liposomes of dopamine hydrochloride for effective management of parkinsonism's PDA Journal of Pharmaceutical Science and Technology 63(5): 372-379
Man'kovskiĭ, N.B.; Karaban', I.N.; Kryzhanovskiĭ, G.N.; Evseev, V.A.; Magaeva, S.V.; Vetrila, L.A.; Trekova, N.A.; Basharova, L.A.; Golubev, K.M. 1993: Dopamine antibodies in parkinsonism patients and their possible role in the pathogenesis of the parkinsonian syndrome Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 93(6): 7-11
Sigwald, J.; Chomette, G.; Raymondeaud, C. 1972: Antagonism and competition between Parkinson's syndrome and the chorea and athetosis syndrome. Clinical cases of the association (including an anatomoclinical case). The abnormal movements provoked by levodopa in Parkinsonian patients La semaine des hopitaux: organe fonde par l'Association d'enseignement medical des hopitaux de Paris 48(9): 609-624
Rosenkranz, R.P.; McClelland, D.L. 1987: Selective antagonism of renal hemodynamic changes induced by dopamine, DPDA, fenoldopam and quinpirole in the rat Proceedings of the Western Pharmacology Society 30: 25-36
Cohenpour, M.; Golan, H. 2007: Nuclear neuroimaging of dopamine transporter in Parkinsonism--role in routine clinical practice Harefuah 146(9): 698-702; 733
Stern, N.; Eggena, P.; Chandler, W.; Tuck, M.L. 1989: Effects of central and peripheral dopamine antagonism on aldosterone secretion: evidence for adrenal mechanism American Journal of Physiology 257(4 Pt 1): E588-E594
Leysen, J.E.; Janssen, P.M.; Megens, A.A.; Schotte, A. 1994: Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity Journal of Clinical Psychiatry 55(Suppl): 5-12
Morelli, A.; Narducci, F.; Camardella, G.; Pelli, M.A.; Floridi, A.; Nenci, G.G. 1977: Dopamine uptake by platelets in hepatic encephalopathy; evidence for a possible depletion of brain dopamine Acta Hepato-Gastroenterologica 24(6): 405-410
Wustmann, C.; Rudolph, E.; Schwipper, U.; Ranacher, B.; Fischer, H.D.; Schmidt, J. 1982: Effect of nootropic drugs on the dopamine release and dopamine uptake in structures of the rat striatum Acta Biologica et Medica Germanica 41(6): 575-579
Allen, E.; Pettigrew, A.; Frank, D.; Thompson, S.; Myers, C.; Yamashita, T.; Blumer, J.L. 1997: Alterations in dopamine clearance and catechol-O-methyltransferase activity by dopamine infusions in children Critical Care Medicine 25(1): 181-189
Wagner, G.C.; Ricaurte, G.A.; Johanson, C.E.; Schuster, C.R.; Seiden, L.S. 1980: Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate Neurology 30(5): 547-550
Shibata, O.; Yorozuya, Y.; Nagatani, A.; Shimada, M.; Haseba, S.; Gotoh, Y.; Honda, Y. 1986: Dopamine and norepinephrine concentrations in the human digestive tract following exogenous dopamine administration Masui. Japanese Journal of Anesthesiology 35(12): 1830-1835
Fukuda, S.; Kobayashi, H.; Mochizuki, T.; Tanaka, M.; Yokoyama, Y.; Hattori, N. 1992: Plasma dopamine, urinary dopamine and their metabolites in chronic renal failure Nihon Jinzo Gakkai Shi 34(9): 1011-1017
Dwoskin, L.P.; Zahniser, N.R. 1986: Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors Journal of Pharmacology and Experimental Therapeutics 239(2): 442-453
Woodruff, G.N.; Freedman, S.B.; Poat, J.A. 1980: Why does sulpiride not block the effect of dopamine on the dopamine-sensitive adenylate cyclase? Journal of Pharmacy and Pharmacology 32(11): 802-803
Tadori, Y.; Kobayashi, H. 2014: The therapeutic plasma concentrations of antiparkinson dopamine agonists and their in vitro pharmacology at dopamine receptors Nihon Shinkei Seishin Yakurigaku Zasshi 34(5-6): 127-132
Lee, F.J.S.; Liu, F.; Pristupa, Z.B.; Niznik, H.B. 2018: Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis FASEB Journal 15(6): 916-926